Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.

about

Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluation.The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects.

P2860

Q40030628-AA6F7EF0-5A3E-43BB-96B2-7540524AAA27 Q46139422-CAE92C24-B56A-4DCB-8D87-D28723A502EE

P2860

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q35665744

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Sildenafil versus nitric oxide ...... lmonary arterial hypertension.

@ast

Sildenafil versus nitric oxide ...... lmonary arterial hypertension.

@en

type

Item

label

Sildenafil versus nitric oxide ...... lmonary arterial hypertension.

@ast

Sildenafil versus nitric oxide ...... lmonary arterial hypertension.

@en

prefLabel

Sildenafil versus nitric oxide ...... lmonary arterial hypertension.

@ast

Sildenafil versus nitric oxide ...... lmonary arterial hypertension.

@en

P1476

Sildenafil versus nitric oxide ...... lmonary arterial hypertension.

@en

P2093

Frank Reichenberger

http://www.w3.org/2001/XMLSchema#string

Henning Gall

http://www.w3.org/2001/XMLSchema#string

Hossein A Ghofrani

http://www.w3.org/2001/XMLSchema#string

Katrin Milger

http://www.w3.org/2001/XMLSchema#string

Robert Voswinckel

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

ATS statement: guidelines for the six-minute walk test.

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Validation of Fick cardiac output calculated with assumed oxygen consumption: a study of cardiac output during epoprostenol.

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.

Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.

Pulmonary hypertension: Hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011.

P304

305-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/680355

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26064455

http://www.w3.org/2001/XMLSchema#string

P932

4449241

http://www.w3.org/2001/XMLSchema#string

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.

about

P2860

P2860

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932